STAT+: Pharmalittle: U.S. Chamber and feds clash on Medicare price negotiation; South Africa probes J&J over TB-drug pricing
Chamber and government lawyers sparred over whether drugmakers have enough say in Medicare’s drug price-negotiation program.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was restful and invigorating because now that familiar routine of meetings and deadlines and what-not has returned. As
